European Archives of Oto-Rhino-Laryngology

, Volume 272, Issue 8, pp 1913–1921 | Cite as

Adenocarcinomas of the sinonasal tract: a case series from an Oncology Centre in Northern Portugal

  • R. Veloso-Teles
  • I. Ribeiro
  • J. Castro-Silva
  • E. Monteiro


Sinonasal malignant neoplasms are rare and adenocarcinomas account for 10–20 % of these cancers. Our aim is to characterise the clinical presentation, risk factors and outcomes of patients with adenocarcinoma treated at our institution. Retrospective review of medical records of patients with sinonasal adenocarcinomas, treated at IPO-Porto from January 2008 until December 2012. Twenty-eight patients with adenocarcinomas were selected from a total of 53 patients with sinonasal cancers. There was a male predominance (93 %), a mean age at diagnosis of 56 years and a rate of occupational wood dust exposure of 71 %. The most common treatment option was surgery followed by adjuvant radiotherapy. The 5 year disease-free and cancer-specific survival was 58 and 60 %, respectively. The following factors had negative impact on disease-free survival: advanced AJCC stage (p = 0.014); skull base invasion (p = 0.002); poorly differentiated or mucinous subtypes histology (p = 0.034) and imaging findings of residual tumour before adjuvant radiotherapy (p < 0.001). Endoscopic tumour resection was not associated with adverse outcomes. The role of volume-modulated arch therapy in the treatment of sinonasal tumours has to be clarified. The higher rate of adenocarcinomas among sinonasal cancers in this series comparing with previous reports, even from our institution, suggests that this pathology is rising in Northern Portugal. Despite substantial local failure, sinonasal adenocarcinomas have a relatively favourable prognosis in terms of cancer-specific survival.


Nasal cancer Paranasal sinus cancer Adenocarcinoma 


  1. 1.
    Turner J, Reh D (2012) Incidence and survival in patients with sinonasal cancer: a historical analysis of population-base data. Head Neck 34:877–885PubMedCrossRefGoogle Scholar
  2. 2.
    Bhayani MK, Yilmaz T, Sweeney A et al (2014) Sinonasal adenocarcinoma: a 16-year experience at a single institution. Head Neck. doi:10.1002/hed.23485 PubMedGoogle Scholar
  3. 3.
    Barnes L (1986) Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 10:192–202PubMedCrossRefGoogle Scholar
  4. 4.
    Lund VJ, Stammberger H, Nikolai P et al (2010) European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl 1(22):1–143Google Scholar
  5. 5.
    Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetic: head and neck tumours. WHO classification of tumours. IARC press, Lyon cedexGoogle Scholar
  6. 6.
    Bernardo T, Ferreira E, Castro Silva J, Monteiro E (2013) Sinonasal adenocarcinoma—experience of an oncology center. Int J Otolaryngol Head Neck Cancer 2:13–16. doi:10.4236/ijohns.2013.21005 CrossRefGoogle Scholar
  7. 7.
    Acheson ED, Hadfield EH, Macbeth RG (1967) Carcinoma of the nasal cavity and accessory sinus in woodworkers. Lancet 1:311–312PubMedCrossRefGoogle Scholar
  8. 8.
    Breheret R, Laccourreye L, Jeufroy C, Bizon A (2011) Adenocarcinoma of the ethmoid sinus: retrospective study of 42 cases. Eur Ann Otorhinolaryngol Head Neck Dis 128(5):211–217PubMedCrossRefGoogle Scholar
  9. 9.
    Orvidas LJ, Lewis JE, Weaver AL et al (2005) Adenocarcinoma of the nose and paranasal sinuses: a retrospective study of diagnosis, histologic characteristics, and outcomes in 24 patients. Head Neck 27(5):370–375PubMedCrossRefGoogle Scholar
  10. 10.
    Gabory L, Maunoury A, Maurice-Tison S et al (2010) Long-term single-center results of management of ethmoid adenocarcinoma: 95 patients over 28 years. Ann Surg Oncol 17(4):1127–1134PubMedCrossRefGoogle Scholar
  11. 11.
    McMonagle BA, Gleeson M (2008) Nasal cavity and paranasal sinus maligancy. In: Scott-Brown MG (ed) Otolaryngology, head and neck surgery, 7th edn. Edward Arnold Publishers, London, pp 2417–2436Google Scholar
  12. 12.
    Choi HR, Sturgis EM, Rashid A et al (2003) Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes. Human Pathol 34(11):1101–1107CrossRefGoogle Scholar
  13. 13.
    Franchi A, Gallo O, Santucci M (1999) Clinical relevance of the histological classification of sinonasal intestinal-type adenocarcinomas. Hum Pathol 30(10):1140–1145PubMedCrossRefGoogle Scholar
  14. 14.
    Leivo I (2007) Update on sinonasal adenocarcinoma: classification and advances in immunophenotype and molecular genetic make-up. Head Neck Pathol 1(1):38–43PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Jardeleza C, Seiberling K, Floreani S, Wormald PJ (2009) Surgical outcomes of endoscopic management of adenocarcinoma of the sinonasal cavity. Rhinology 47(4):354–361PubMedGoogle Scholar
  16. 16.
    Nicolai P, Villaret AB, Bottazzoli M et al (2011) Ethmoid adenocarcinoma–from craniofacial to endoscopic resections: a single-institution experience over 25 years. Otolaryngol Head Neck Surg 145(2):330–337PubMedCrossRefGoogle Scholar
  17. 17.
    Gomez-Millan J, Jerez Sainz I, Perez Rozos A et al (2014) Potential advantages of volumetric arc therapy (VMAT) in head and neck cancer. Head Neck. doi:10.1002/hed.23685 Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • R. Veloso-Teles
    • 1
    • 3
  • I. Ribeiro
    • 2
  • J. Castro-Silva
    • 3
  • E. Monteiro
    • 3
  1. 1.Department of OtorhinolaryngologyAlto Ave Hospital Centre (CHAA)GuimarãesPortugal
  2. 2.Department of RadiotherapyPortuguese Institute of Oncology in Porto (IPO-Porto)PortoPortugal
  3. 3.Department of OtorhinolaryngologyPortuguese Institute of Oncology in Porto (IPO-Porto)PortoPortugal

Personalised recommendations